<!DOCTYPE html>
<html lang="en">
<head><!-- Google Tag Manager --> <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-N4XZHNC');</script> <!-- End Google Tag Manager -->

<title>Bladder Cancer: Tumor Stages and Pathology</title>
  <meta charset="utf-8">
  
  <link href="urology.css" rel="stylesheet">
	  
<meta name="keywords" content="bladder cancer tumor stages, bladder carcinoma pathology" >
<meta name="description" content="Tumor stages and pathology of bladder cancer..., from the online textbook of urology by D. Manski" >
<meta name="author" content="Dr. med. Dirk Manski" >
<meta name="copyright" content="Dirk Manski" >
<meta name="robots" content="index">
<meta name="robots" content="follow">
<meta name="viewport" content="width=device-width, initial-scale=1">
 </head>

<body><!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-N4XZHNC" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
<header>
    <a class="ribbon" tabindex="-1" title="back to start!" href="https://www.urology-textbook.com/index.html">
	   <h5 id="logo">urology-textbook.com</h5>
       <p>Dr. med. Dirk Manski</p>
    </a>  
</header>
<main>
<nav id="navigation">
<ul>
<li><a href="https://www.urology-textbook.com/index.html">Start</a></li>
<li><a href="https://www.urology-textbook.com/anatomy.html">Anatomy</a></li>
<li><a href="https://www.urology-textbook.com/signs-and-symptoms.html">Signs and Symptoms</a></li>
<li><a href="https://www.urology-textbook.com/examinations.html">Examinations</a></li>
<li><a href="https://www.urology-textbook.com/surgical-management.html">Surgical Management</a></li>
<li><a href="https://www.urology-textbook.com/pharmacology.html">Pharmacology</a></li>
<li><a href="https://www.urology-textbook.com/kidneys.html">Kidneys</a></li>
<li><a href="https://www.urology-textbook.com/ureters.html">Ureters</a></li>
<li><a href="https://www.urology-textbook.com/bladder.html">Bladder</a></li>
<li><a href="https://www.urology-textbook.com/prostate.html">Prostate</a></li>
<li><a href="https://www.urology-textbook.com/urethra.html">Urethra</a></li>
<li><a href="https://www.urology-textbook.com/penis.html">Penis</a></li>
<li><a href="https://www.urology-textbook.com/testes.html">Testes</a></li>
<li><a href="https://www.urology-textbook.com/adrenal-glands.html">Adrenal Glands</a></li>
<li><a href="https://www.urology-textbook.com/common-diseases.html">Common Diseases</a></li>
<li><a href="https://www.urology-textbook.com/urologic-surgery.html">Urologic Surgery</a></li>
<li><a href="https://www.urology-textbook.com/index-urology.html">Index</a></li>
<li><a href="https://www.urology-textbook.com/medical-abbreviations.html">Abbreviations</a></li>
<li><a href="https://www.urology-textbook.com/urology-news.html">News</a></li>
<li><a href="https://www.urology-textbook.com/links.html">Links</a></li>
</ul>



 
</nav>
<article>

<p id="brotkrumen">&nbsp;You are here: <a href="https://www.urology-textbook.com/index.html">Urology Textbook</a> &gt; <a href="https://www.urology-textbook.com/bladder.html">Bladder</a> &gt; <a href="https://www.urology-textbook.com/bladder-cancer.html">Bladder cancer</a> Pathology</p><!-- Main content -->

<h1>Bladder cancer (2/7): Tumor Stages and Pathology</h1>

<p>Review Literature: <a href="http://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/">EAU guidelines superficial bladder cancer</a>. <a href="http://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/">EAU guidelines of muscle-invasive and metastatic bladder cancer</a>. <a href="http://www.leitlinienprogramm-onkologie.de/leitlinien/harnblasenkarzinom/">German S3 guidelines bladder carcinoma Harnblasenkarzinom</a>.
</p>

<ul>
    <li><a href="https://www.urology-textbook.com/bladder-cancer.html">Bladder carcinoma: Definition, Epidemiology and Etiology</a></li>
    <li><strong>Bladder carcinoma: Pathology and TNM tumor stages</strong></li>
    <li><a href="https://www.urology-textbook.com/bladder-cancer-diagnosis.html">Bladder carcinoma: Symptoms and Diagnosis</a></li>
    <li><a href="https://www.urology-textbook.com/bladder-cancer-treatment.html">Bladder carcinoma: Surgical Treatment</a></li>
    <li><a href="https://www.urology-textbook.com/bladder-cancer-chemotherapy.html">Bladder carcinoma: Chemotherapy and Immunotherapy of Metastases</a></li>
</ul>

<h2>TNM Tumor Staging of Bladder Cancer</h2>

<h3>Superficial bladder carcinoma: </h3>

<ul>
<li>Ta: noninvasive papillary tumor
</li>
<li> Tis: flat high-grade tumor without polarity and without invasion</li>
<li> T1: Tumor with infiltration of the subepithelial connective tissue (lamina submucosa)</li>
</ul>

<h3>T2: Tumor invades muscle (tunica muscularis).</h3>
<ul>
<li>T2a: infiltration of the inner half of the lamina muscularis
</li>
<li> T2b: infiltration of the outer half of the lamina muscularis
</li>
</ul>

<br>


 
<h3>T3: Tumor invades perivesical tissue.</h3>
<ul>
<li> T3a: microscopic perivesical infiltration</li>
<li> T3b: macroscopic perivesical infiltration</li>
</ul>

<h3>T4: Tumor invades adjacent organs.</h3>
<ul>
<li>T4a: infiltration of prostate, uterus or vagina
</li>
<li>T4b: infiltration of the pelvic or abdominal wall
</li>
</ul>

<h3>N: Lymph node involvement.</h3>
<ul>
<li>N0: no regional lymph node metastasis
</li>
<li>N1: solitary regional lymph node metastasis (in the true pelvis hypogastric, obturator, external iliac, or presacral).
</li>
<li>N2: multiple regional lymph node metastasis (in the true pelvis hypogastric, obturator, external iliac, or presacral).
</li>
<li>N3: metastases in common iliac lymph node(s).
</li>
</ul>

<h3>M: Distant metastasis.</h3>

<ul>
<li> M0: no distant metastasis
</li>
<li> M1: distant metastasis
</li>
</ul>

<h3>G: Grading.</h3>

<ul>
<li>Urotheliale papilloma (completely benign lesion)</li>
<li> Papillary urothelial neoplasm of low malignant potential (PUNLMP)</li>
<li>Low grade bladder cancer: corresponding to G1 (well differentiated) and partly to G2 (intermediate differentiated) of the WHO 1973 classification
</li>
<li>High grade bladder cancer: corresponding to partly G2 and G3 (poor to undifferentiated) of the WHO 1973 classification
</li>
</ul>

<h2>Macroscopic Pathology of Bladder Cancer </h2>

<h4>Localization:</h4>
<p>Bladder cancer most commonly begins at the side walls or posterior wall in 70%. Less common bladder neck and trigone (20%) or anterior wall in 10%. A multifocal growth can be seen in 50%. </p>

<h4>Growth pattern: </h4>
<p>The initial growth pattern is either flat and/or exophytic. In advanced disease, the tumor infiltrats the detrusor muscle and adjacent organs [Fig. <a href="#Harnblasenkarzinom_Pathologie1">advanced bladder cancer</a>]. </p>

<script type="steady-switch" data-when="subscription"><!--
<a NAME="Harnblasenkarzinom_Pathologie1"></a>
<table width=100%>
<tr> <td> <img src="https://images1.urology-textbook.com/Harnblasenkarzinom_Pathologie1.jpg" alt="figure OP specimen of an advanced bladder cancer" title=”advanced bladder cancer”> </td></tr>
<tr>
<caption><strong>Specimen of an advanced bladder cancer with infiltration of the sigma: </strong> the urinary bladder has been opened at the anterior wall, the catheter marks the bladder neck. With kind permission, Dr. R. Gumpinger, Kempten. See also <a href="#Urogramm_Harnblasenkarzinom1">IVP</a> and <a href="#CT_Harnblasenkarzinom1">CT</a> of the same patient. </caption>
</table>
--></script>
 

<script type="steady-switch" data-when="no-subscription"><!--
<table width=100%>
<caption><strong>Specimen of an advanced bladder cancer with infiltration of the sigma: </strong> the urinary bladder has been opened at the anterior wall, the catheter marks the bladder neck. With kind permission, Dr. R. Gumpinger, Kempten. See also <a href="#Urogramm_Harnblasenkarzinom1">IVP</a> and <a href="#CT_Harnblasenkarzinom1">CT</a> of the same patient. </caption>
<tr><td>Do you want to see the illustration? Please support this website with a <a href="https://steadyhq.com/en/urology/about">Steady membership</a>. In return, you will get access to all images and eliminate the advertisements. Please note: some medical illustrations in urology can be disturbing, shocking, or disgusting for non-specialists. <a href="https://www.urology-textbook.com/members.html">Click here for more information.</a></td></tr>
</table>
--></script>
 

<h4>Lymph node metastasis: </h4>
<p>Lymphogenic metastases may affect the iliac, obturator, presacral and aortic lymph node groups. The probability of lymph node metastasis is 5% for pT1 tumors, 30% for pT2 and 60% for pT3b tumors. </p>

<h4>Distant metastases: </h4>
<p>Bone, liver, lung, peritoneum, brain. The risk for distant metastasis is 50% for locally advanced tumors (&geq; stage pT3b). </p>

<h2>Microscopic Pathology </h2>
<p>Over 95% of bladder cancers are urothelial carcinomas (synonym: transitional cell carcinoma), 2% are squamous cell carcinomas and 1% are adenocarcinomas. Urothelial lesions are divided into expophytic papillary lesions or flat lesions (Helpap and Koller, 2000).
</p>

<h4>Exophytic and papillary urothelial lesions: </h4>

<h5>Papilloma: </h5>
<p>Sharply defined and intact superficial umbrella layer, no mitotic activity. Benign lesion. </p>

<h5>Papillary urothelial neoplasm of low malignant potential (PUNLMP): </h5>
<p>Increasingly nuclear atypia, interupted superficial umbrella layer,  increased urothelial cell layers.  </p>

<h5>Papillary bladder carcinoma: </h5>
<p>Palisading predominantly present, less or more nuclear atypia depends on grading, superficial umbrella layer often not present, increased urothelial cell layers. Malignant lesion. Invasive bladder cancer: infiltration beyond the basal membrane into the lamina propria or muscularis. </p>

<h4>Flat urothelial lesions:</h4>

<h5>Flat hyperplasia: </h5>
<p>More than 7 cell layers without cellular atypia and intact polarity of the urothelium. Benign. </p>

<h5>Reactive atypia: </h5>
<p>More than 7 cell layers with slight cellular atypia. Benign. </p>

<h5>Dysplasia: </h5>
<p>Flat atypical urothelium with disorders in polarity, partially preserved palisading. Benign. </p>

<h5>Carcinoma in situ: </h5>
<p>Typical features of carcinoma in situ are prominent nuclear atypia, disorders of polarity, mitotic activity, high proliferation (MIB-1). Malignant with a high risk of progression. </p>

<h4>Reproducibility of the pathological staging: </h4>
<p>T stage 50-80% conformity, grading 60-75% conformity. Interobserver variation is even higher for flat high grade lesions.
</p>

<h2>Rare Carcinomas of the Urinary Bladder </h2>

<h4>Squamous cell carcinoma: </h4> 
<p>Risk factors for squamous cell carcinoma are chronic infections, schistosomiasis, or chronic indwelling bladder catheter. Prognosis is comparable to transitional cell carcinoma. </p>

<h4>Adenocarcinoma: </h4> 
<p>Either primary adenocarcinoma from the bladder, often from the urachus. Secondary adenocarcinoma from urinary diversion with bowel segments or from bladder metastasis. </p>.

<h4>Neoplasms of the urachus: </h4> 
<p> Neoplasms of the urachus are located at the bladder roof or arise from the extravesical part of the urachus. Adenocarcinoma is the most common type of this rare neoplasia, but transitional cell carcinoma or sarcoma is also possible. </p>

<h4>Small cell carcinoma of the bladder: </h4> 
<p>The bladder is the most common extrapulmonary manifestation of small cell carcinoma. The prognosis is poor. </p>

<h4>Other rare cancers: </h4> 
<p>Hepatoid adenocarcinoma, lymphoepithelial carcinoma, carcinoid tumors (neuroendocrine tumors), germ cell tumors. </p>

<h2>Nonepithelial tumors of the urinary bladder </h2>

<h4>Benign, nonepithelial tumors: </h4> 
<p>Leiomyoma, rhabdomyoma, hemangioma, lipoma, neurofibroma. </p>

<h4>Sarcomas: </h4> 
<p>Please see section sarcoma of the bladder</p>

<h4>Primary malignant lymphoma: </h4> 
<p>Malignant lymphoma of the bladder may present either as primary lymphoma localized to the bladder, bladder lymphoma in the context of disseminated disease or secondary bladder lymphoma in patients with a history of malignant lymphoma. Primary bladder lymphoma arises from the mucosa associated lymphoid tissue (MALT) and is associated with an excellent prognosis. </p>

<h4>Pheochromocytoma: </h4> <p>Pheochromocytoma of the bladder are tumors from paravesical ganglia. Paroxysmal hypertension may be associated with micturition. </p>

<h4>Metastasis of the urinary bladder </h4>

<p>Infiltrative growth of tumors into the bladder wall from female genital organs, prostate or colon are more common than distant metastases caused by malignant melanoma, gastric cancer, breast cancer or lung cancer. </p>
<br>
<br>

<table id="navigation_unten">
<tr>
 
<td><a href="https://www.urology-textbook.com/bladder-cancer.html">Bladder cancer: </a></td>
<td><a class="nav4" href="https://www.urology-textbook.com/index-urology.html">Index</a></td>
<td><a class="nav3" href="https://www.urology-textbook.com/bladder-cancer-diagnosis.html">Bladder cancer diagnosis</a></td>
 
</tr>
</table>

<br>
<br>
Index: <a href="https://www.urology-textbook.com/index-urology-a.html">1&ndash;9</a> <a href="https://www.urology-textbook.com/index-urology-a.html">A</a> <a href="https://www.urology-textbook.com/index-urology-b.html">B</a> <a href="https://www.urology-textbook.com/index-urology-c.html">C</a> <a href="https://www.urology-textbook.com/index-urology-d.html">D</a> <a href="https://www.urology-textbook.com/index-urology-e.html">E</a> <a href="https://www.urology-textbook.com/index-urology-f.html">F</a> <a href="https://www.urology-textbook.com/index-urology-g.html">G</a> <a href="https://www.urology-textbook.com/index-urology-h.html">H</a> <a href="https://www.urology-textbook.com/index-urology-i.html">I</a> <a href="https://www.urology-textbook.com/index-urology-j.html">J</a> <a href="https://www.urology-textbook.com/index-urology-k.html">K</a> <a href="https://www.urology-textbook.com/index-urology-l.html">L</a> <a href="https://www.urology-textbook.com/index-urology-m.html">M</a> <a href="https://www.urology-textbook.com/index-urology-n.html">N</a> <a href="https://www.urology-textbook.com/index-urology-o.html">O</a> <a href="https://www.urology-textbook.com/index-urology-p.html">P</a> <a href="https://www.urology-textbook.com/index-urology-q.html">Q</a> <a href="https://www.urology-textbook.com/index-urology-r.html">R</a> <a href="https://www.urology-textbook.com/index-urology-s.html">S</a> <a href="https://www.urology-textbook.com/index-urology-t.html">T</a> <a href="https://www.urology-textbook.com/index-urology-u.html">U</a> <a href="https://www.urology-textbook.com/index-urology-v.html">V</a> <a href="https://www.urology-textbook.com/index-urology-w.html">W</a> <a href="https://www.urology-textbook.com/index-urology-xyz.html">X Y Z</a> 

<br>
<br>
<h3>References</h3>

<p>Abol-Enein, H.
    Infection: is it a cause of bladder 
        cancer?<br><em>Scand J Urol Nephrol Suppl, </em><b>2008</b>, 79-84.</p>


<p><a NAME="Amin1997">
    Amin und Young 1997 A<SMALL>MIN</SMALL>, M.&nbsp;B.&nbsp;; Y<SMALL>OUNG</SMALL>, R.&nbsp;H.:
        </a>
     Primary carcinomas of the <a href="https://www.urologielehrbuch.de/harnroehre.html">urethra</a>.
    <br> In: <I>Semin Diagn Pathol</I>
    <br> 14 (1997), Nr.&nbsp;2, S.&nbsp;147&ndash;60</p>


<p>Babjuk, M.; Burger, M.; Comp&#233;rat, E.; Gonter, P.; 
        Mostafid, A.; Palou, J.; van Rhijn, B.; Roupr&#234;t, M.; Shariata, S.; 
        Sylvester, R. &amp; Zigeuner, R.<br>Non-muscle-invasive Bladder CancerEAU 
        Guidelines, <b>2020</b> <a href="http://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/">http://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/</a> </p>


<p>Brinkman, M. &amp; Zeegers, M. P.
       Nutrition, total 
        fluid and bladder cancer.<br><em>Scand J Urol Nephrol Suppl, </em><b>2008</b>, 
        25-36.</p>

<p>Cohn, J. A.; Vekhter, B.; Lyttle, C.; Steinberg, 
        G. D. &amp; Large, M. C.
        Sex disparities in diagnosis of bladder cancer 
        after initial presentation with hematuria: a nationwide claims-based 
        investigation.<br><em>Cancer, </em><b>2014</b><i>, 120</i>, 555-561</p>

 <p>
     DGU; DKG; DKG &amp; Leitlinienprogramm Onkologie
     S3-Leitlinie (Langfassung): Fr&#252;herkennung, Diagnose, Therapie und Nachsorge des 
        Harnblasenkarzinoms. <a href="http://www.leitlinienprogramm-onkologie.de/leitlinien/harnblasenkarzinom/">http://www.leitlinienprogramm-onkologie.de/leitlinien/harnblasenkarzinom/</a>
 </p>
  
    
<p>
<a NAME="Helpap2000">
Helpap und Kollermann 2000 H<SMALL>ELPAP</SMALL>, B.&nbsp;;
  K<SMALL>OLLERMANN</SMALL>, J.:
    </a>
 [Revisions in the WHO histological classification of urothelial
  bladder tumors and flat urothelial lesions].
<br> In: <I>Pathologe</I>
    <br> 21 (2000), Nr.&nbsp;3, S.&nbsp;211&ndash;7</p>

<p>IARC (2004)
    <a href="http://monographs.iarc.fr/ENG/Monographs/vol83/mono83.pdf">Monographs on the Evaluation of Carcinogenic Risks to Humans</a>. Volume 83. Tobacco Smoke and Involuntary Smoking. World Health Organization. </p>
  
<p>
<a NAME="Kalble2001">
Kalble 2001 K<SMALL>ALBLE</SMALL>, T.:
    </a>
 [Etiopathology, risk factors, environmental influences and
  epidemiology of bladder cancer].
<br> In: <I>Urologe A</I>
    <br> 40 (2001), Nr.&nbsp;6, S.&nbsp;447&ndash;50</p>
    
<p>
<a NAME="Kataja2005">
Kataja und Pavlidis 2005 K<SMALL>ATAJA</SMALL>, V.&nbsp;V.&nbsp;;
  P<SMALL>AVLIDIS</SMALL>, N.:
    </a>
 ESMO Minimum Clinical Recommendations for diagnosis, treatment and
  follow-up of invasive bladder cancer.
<br> In: <I>Ann Oncol</I>
    <br> 16 Suppl 1 (2005), S.&nbsp;i43&ndash;4</p>
    
<p>
<a NAME="Krieg1999">
Krieg und Hoffman 1999 K<SMALL>RIEG</SMALL>, R.&nbsp;; H<SMALL>OFFMAN</SMALL>, R.:
    </a>
 Current management of unusual genitourinary cancers. Part 2: Urethral
  cancer.
<br> In: <I>Oncology (Williston Park)</I>
    <br> 13 (1999), Nr.&nbsp;11, S.&nbsp;1511&ndash;7, 1520; discussion 1523&ndash;4</p>

<p>Lammers, R. J. M.; Witjes, W. P. J.; Hendricksen, K.; 
        Caris, C. T. M.; Janzing-Pastors, M. H. C. &amp; Witjes, J. A.
        Smoking 
        status is a risk factor for recurrence after transurethral resection of 
        non-muscle-invasive bladder cancer.<br><em>Eur Urol, </em><b>2011</b><i>, 
        60</i>, 713-720</p>

<p>
<a NAME="Lampel1998a">
Lampel und Thuroff 1998a L<SMALL>AMPEL</SMALL>, A.&nbsp;;
  T<SMALL>HUROFF</SMALL>, J.&nbsp;W.:
    </a>
 [Bladder carcinoma 1: Radical cystectomy, neoadjuvant and adjuvant
  therapy modalities].
<br> In: <I>Urologe A</I>
    <br> 37 (1998), Nr.&nbsp;1, S.&nbsp;93&ndash;101</p>

<p>
<a NAME="Lampel1998b">
Lampel und Thuroff 1998b L<SMALL>AMPEL</SMALL>, A.&nbsp;;
  T<SMALL>HUROFF</SMALL>, J.&nbsp;W.:
    </a>
 [Bladder carcinoma. 2: Urinary diversion].
<br> In: <I>Urologe A</I>
    <br> 37 (1998), Nr.&nbsp;2, S.&nbsp;W207&ndash;20</p>
    
<p>
<a NAME="Leppert2006">
Leppert u.a. 2006 L<SMALL>EPPERT</SMALL>, J.&nbsp;T.&nbsp;; S<SMALL>HVARTS</SMALL>,
  O.&nbsp;; K<SMALL>AWAOKA</SMALL>, K.&nbsp;; L<SMALL>IEBERMAN</SMALL>, R.&nbsp;; B<SMALL>ELLDEGRUN</SMALL>,
  A.&nbsp;S.&nbsp;; P<SMALL>ANTUCK</SMALL>, A.&nbsp;J.:
    </a>
 Prevention of bladder cancer: a review.
<br> In: <I>Eur Urol</I>
    <br> 49 (2006), Nr.&nbsp;2, S.&nbsp;226&ndash;34</p>

<p>Liu, S.; Yang, T.; Na, R.; Hu, M.; Zhang, L.; Fu, 
        Y.; Jiang, H. &amp; Ding, Q.<br>The impact of female gender on bladder 
        cancer-specific death risk after radical cystectomy: a meta-analysis of 
        27,912 patients.
        <em>International urology and nephrology, </em><b>2015</b><i>, 
        47</i>, 951-958
    </p>

<p>
<a NAME="Michaud1999">
Michaud u.a. 1999 M<SMALL>ICHAUD</SMALL>, D.&nbsp;S.&nbsp;; S<SMALL>PIEGELMAN</SMALL>,
  D.&nbsp;; C<SMALL>LINTON</SMALL>, S.&nbsp;K.&nbsp;; R<SMALL>IMM</SMALL>, E.&nbsp;B.&nbsp;; C<SMALL>URHAN</SMALL>,
  G.&nbsp;C.&nbsp;; W<SMALL>ILLETT</SMALL>, W.&nbsp;C.&nbsp;; G<SMALL>IOVANNUCCI</SMALL>, E.&nbsp;L.:
    </a>
 Fluid intake and the risk of bladder cancer in men.
<br> In: <I>N Engl J Med</I>
    <br> 340 (1999), Nr.&nbsp;18, S.&nbsp;1390&ndash;7</p>
    
<p>
<a NAME="Plna2001">
Plna und Hemminki 2001 P<SMALL>LNA</SMALL>, K.&nbsp;; H<SMALL>EMMINKI</SMALL>, K.:
    </a>
 Familial bladder cancer in the National Swedish Family Cancer
  Database.
<br> In: <I>J Urol</I>
    <br> 166 (2001), Nr.&nbsp;6, S.&nbsp;2129&ndash;33</p>

<p>
<a NAME="Rajan1993">
Rajan u.a. 1993 R<SMALL>AJAN</SMALL>, N.&nbsp;; T<SMALL>UCCI</SMALL>, P.&nbsp;;
  M<SMALL>ALLOUH</SMALL>, C.&nbsp;; C<SMALL>HOUDHURY</SMALL>, M.:
    </a>
 Carcinoma in female urethral diverticulum: case reports and review of
  management.
<br> In: <I>J Urol</I>
    <br> 150 (1993), Nr.&nbsp;6, S.&nbsp;1911&ndash;4</p>

<p>
    Robert-Koch-Institut (2015)
    Krebs in Deutschland 2011/2012. <a href="http://www.krebsdaten.de">www.krebsdaten.de</a>
</p>
  
<p>
Stein u.a. 2001 S<SMALL>TEIN</SMALL>, J.&nbsp;P.&nbsp;; L<SMALL>IESKOVSKY</SMALL>,
  G.&nbsp;; C<SMALL>OTE</SMALL>, R.&nbsp;; G<SMALL>ROSHEN</SMALL>, S.&nbsp;; F<SMALL>ENG</SMALL>, A.&nbsp;C.&nbsp;;
  B<SMALL>OYD</SMALL>, S.&nbsp;; S<SMALL>KINNER</SMALL>, E.&nbsp;; B<SMALL>OCHNER</SMALL>, B.&nbsp;;
  T<SMALL>HANGATHURAI</SMALL>, D.&nbsp;; M<SMALL>IKHAIL</SMALL>, M.&nbsp;; R<SMALL>AGHAVAN</SMALL>, D.&nbsp;;
    S<SMALL>KINNER</SMALL>, D.&nbsp;G.:
 Radical cystectomy in the treatment of invasive bladder cancer:
  long-term results in 1054 patients.
<br> In: <I>J Clin Oncol</I>
    <br> 19 (2001), Nr.&nbsp;3, S.&nbsp;666&ndash;75</p>

<p>
<a NAME="Weissbach2001">
Weissbach 2001 W<SMALL>EISSBACH</SMALL>, L.:
    </a>
 [Palliation of urothelial carcinoma of the bladder].
<br> In: <I>Urologe A</I>
    <br> 40 (2001), Nr.&nbsp;6, S.&nbsp;475&ndash;9</p>

<p>
    Witjes, J.; Comp&#233;rat, E.; Cowan, N.; Gakis, G.; 
        Hern&#225;nde, V.; Lebret, T.; Lorch, A.; van der Heijden, A. &amp; Ribal, M.
        Muscle-invasive 
        and Metastatic Bladder Cancer<br><em>EAU Guidelines, </em><b>2020</b> <a href="http://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/">http://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/</a>
</p>


<br>
<br>
<p><img src="https://images0.urology-textbook.com/deutsch.gif">&nbsp; Deutsche Version: <a href="https://www.urologielehrbuch.de/harnblasenkarzinom-tnm-tumorstadien.html">Pathologie und TNM Tumor Staging des Harnblasenkarzinoms</a></p>

</article>
</main>
<footer class="grid">
    <ul id="footer-nav">
    		<li>Copyright by Dr. med. Dirk Manski </li>
		<li><a href="https://www.urology-textbook.com/privacy-policy.html">Privacy policy</a></li>
		<li><a href="https://www.urology-textbook.com/disclaimer.html">Disclaimer</a></li>
	</ul>
	<a class="steady-login-button" data-size="medium" data-language="en" style="display: none;"></a>
	
<img src="https://vg08.met.vgwort.de/na/3a00af3d38854f1ab8f88f10018bdad5" width="1" height="1" alt="">


</footer>
</body>
</html>
